EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Improvement in Protective Sensation: Clinical Evidence From a Randomized Controlled Trial for Treatment of Painful Diabetic Neuropathy With 10 kHz Spinal Cord Stimulation

Charles E Argoff, David G Armstrong iD, Zachary B Kagan iD, Michael J Jaasma, Manish Bharara, Kerry Bradley, David L Caraway, Erika A Petersen, for Investigators

Journal of Diabetes Science and Technology · 2025

DOI: 10.1177/19322968231222271 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Diabetes Science and Technology, 2025. Verfasst von Charles E Argoff und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Albany Medical Center, Albany, NY, USA. Hauptthemen laut MEDLINE: Spinal Cord Stimulation, Diabetic Neuropathies, Sensation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, Nevro Corp..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Painful diabetic neuropathy (PDN) can result in the loss of protective sensation, in which people are at twice the likelihood of foot ulceration and three times the risk of lower extremity amputation. Here, we evaluated the long-term effects of high-frequency (10 kHz) paresthesia-independent spinal cord stimulation (SCS) on protective sensation in the feet and the associated risk of foot ulceration for individuals with PDN.

Methods

The SENZA-PDN clinical study was a randomized, controlled trial in which 216 participants with PDN were randomized to receive either conventional medical management (CMM) alone or 10 kHz SCS plus CMM, with optional treatment crossover after 6 months. At study visits (baseline through 24 months), 10-g monofilament sensory assessments were conducted at 10 locations per foot. Two published methods were used to evaluate protective sensation via classifying risk of foot ulceration.

Results

Participants in the 10 kHz SCS group reported increased numbers of sensate locations as compared to CMM alone ( P < .001) and to preimplantation ( P < .01) and were significantly more likely to be at low risk of foot ulceration using both classification methods. The proportion of low-risk participants approximately doubled from preimplantation to 3 months postimplantation and remained stable through 24 months ( P ≤ .01).

Conclusions

Significant improvements were observed in protective sensation from preimplantation to 24 months postimplantation for the 10 kHz SCS group. With this unique, disease-modifying improvement in sensory function, 10 kHz SCS provides the potential to reduce ulceration, amputation, and other severe sequelae of PDN. Trial Registration: The SENZA-PDN study is registered on ClinicalTrials.gov with identifier NCT03228420.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord StimulationDiabetic NeuropathiesSensationHumansFemaleMaleMiddle AgedAgedDiabetic FootTreatment OutcomeAdult

Stichwörter der Autor:innen

chronic paindiabetesneuromodulationneuropathy

Autor:innen und Institutionen

  • Department of Neurology, Albany Medical Center, Albany, NY, USA.
  • Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Nevro Corp, Redwood City, CA, USA.
  • Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

ORCID-Profile: David G Armstrong, Zachary B Kagan

Förderung

  • NIDDK NIH HHS
  • Nevro Corp.

Zitieren

APA

Argoff, C. E., Armstrong, D. G., Kagan, Z. B., Jaasma, M. J., Bharara, M., Bradley, K., Caraway, D. L., Petersen, E. A., & for Investigators (2025). Improvement in Protective Sensation: Clinical Evidence From a Randomized Controlled Trial for Treatment of Painful Diabetic Neuropathy With 10 kHz Spinal Cord Stimulation. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968231222271

Vancouver

Argoff CE, Armstrong DG, Kagan ZB, Jaasma MJ, Bharara M, Bradley K, et al. Improvement in Protective Sensation: Clinical Evidence From a Randomized Controlled Trial for Treatment of Painful Diabetic Neuropathy With 10 kHz Spinal Cord Stimulation. Journal of Diabetes Science and Technology. 2025. doi:10.1177/19322968231222271

BibTeX
@article{Argoff2025,
  author = {Argoff, Charles E and Armstrong, David G and Kagan, Zachary B and Jaasma, Michael J and Bharara, Manish and Bradley, Kerry and Caraway, David L and Petersen, Erika A and for Investigators, for Investigators},
  title = {Improvement in Protective Sensation: Clinical Evidence From a Randomized Controlled Trial for Treatment of Painful Diabetic Neuropathy With 10 kHz Spinal Cord Stimulation},
  journal = {Journal of Diabetes Science and Technology},
  year = {2025},
  doi = {10.1177/19322968231222271}
}
Kostenlos starten →